| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/18/2007 | CN1947694A Method for producing black mud by using lake salt as ra material |
| 04/18/2007 | CN1947693A Method for producing black mud by using well mineral salt as raw material |
| 04/18/2007 | CN1947692A Artificial compound black mud |
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310947C Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics |
| 04/18/2007 | CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/18/2007 | CN1310917C Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 04/18/2007 | CN1310884C Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-[(3S)-3-hydroxypyrrolidine-1-y1)ethyl]-2, 2-diphenyl acetamide |
| 04/18/2007 | CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/18/2007 | CN1310870C Enantiomerically enriched 1-phenylethylamines |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310666C Pure Chinese medicine original medicinal pad for diminishing inflammation, relieving pain and dissipating mass |
| 04/18/2007 | CN1310656C Chinese medicine prepn for treating pain in neck, shoulder, waist and leg |
| 04/18/2007 | CN1310652C Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
| 04/18/2007 | CN1310640C Pharmaceutical compositions |
| 04/18/2007 | CN1310636C Paederia powder injection and its preparation method |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205383 Peptide ligands of leukocyte integrins |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205308 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/17/2007 | CA2166292C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 04/17/2007 | CA2153789C Biologically active tgf-.beta.1 and tgf-.beta.2 peptides |
| 04/17/2007 | CA2124260C Tetrahydropyran derivatives |
| 04/17/2007 | CA2123912C Muramyl compounds for treatment of septic shock |
| 04/12/2007 | WO2007041694A2 Compositions and methods for treating inflammation |
| 04/12/2007 | WO2007041435A1 Methods for treating pain and hyperhidrosis |
| 04/12/2007 | WO2007041357A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | WO2007041327A1 Compositions comprising hypsizygus ulmarius extract |
| 04/12/2007 | WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007041130A2 Deazapurines useful as inhibitors of janus kinases |
| 04/12/2007 | WO2007041076A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | WO2007040435A1 Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040188A1 Medicinal composition for inhibiting the excessive formation of goblet cells |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007039797A1 Use of cannabinoid receptor-1 antagonist for treating inflammation and arthritis |
| 04/12/2007 | WO2007039616A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 04/12/2007 | WO2007039581A1 Imidazolyl-substituted diazabenzophenone compounds |
| 04/12/2007 | WO2007039580A1 Imidazolyl-substituted benzophenone compounds |
| 04/12/2007 | WO2007039578A1 Imidazolyl-substituted azabenzophenone compounds |
| 04/12/2007 | WO2007039467A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 04/12/2007 | WO2007039286A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 04/12/2007 | WO2007039285A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | WO2007039114A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 04/12/2007 | WO2007038870A1 A DAIRY DERIVED COMPOSITION ENRICHED IN TGF-β FOR TREATING INFLAMMATION |
| 04/12/2007 | WO2007023115A3 P38 map kinase inhibitors and methods for using the same |
| 04/12/2007 | WO2007023115A2 P38 map kinase inhibitors and methods for using the same |
| 04/12/2007 | WO2007017264A3 Pyrrolopyridinederivatives as modulators of the cannabinoid receptor for the treatment of immune and inflammatory disorders |
| 04/12/2007 | WO2006124692A3 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same |
| 04/12/2007 | WO2006105058A3 Trihydroxy polyunsaturated eicosanoid derivatives |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082956 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity. |
| 04/12/2007 | US20070082954 Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives |
| 04/12/2007 | US20070082930 Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082903 Remedy for rheumatoid arthritis |
| 04/12/2007 | US20070082898 5 Amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
| 04/12/2007 | US20070082850 Derivatives of mannose-6-phosphate that are resistant to phosphatase and mannosidase enzymes; for treatment of disease or condition wherein T lymphocyte migration from blood to tissue or other extravascular site is step in development of the disease or condition; 1-methyl-2,3,4,6-tetrabenzyl-mannoside |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | CA2624730A1 Compositions and methods for treating inflammation |
| 04/12/2007 | CA2624524A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624493A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 04/12/2007 | CA2624488A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 04/12/2007 | CA2624468A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | CA2624450A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624357A1 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624354A1 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624345A1 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2623822A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | CA2623154A1 Novel fused pyrrole derivative |
| 04/12/2007 | CA2623058A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 04/12/2007 | CA2623032A1 Deazapurines useful as inhibitors of janus kinases |